Mindbytes May 29, 2025
FDA Embraces AI to Expedite Drug Reviews
The U.S. Food and Drug Administration (FDA) is rapidly integrating AI into its regulatory processes, aiming to enhance efficiency and reduce review times across all centers.
gizmoguru